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INTRODUCTION 
 Until a few years ago, it was generally believed that a breast 
tumour should be excised and histologically examined to determine 
its nature with certainty – because the preoperative physical 
assessment alone was associated with too much uncertainty. 
 Eventually, with the advent of mammography, a radiological 
tool became available to the surgeons to make a pre-operative 
diagnosis of the breast with a reasonable degree of accuracy.  
However, it was the introduction of FNAC that changed the entire 
outlook to the matter.  The combination of clinical examination, 
Mammography and FNAC came to be called upon as the ‘Triple 
Test’ for assessment of breast lumps and has now become the gold 
standard in the work-up of the same. 
 Breast Ultrasound has now become available at higher 
resolutions, and is proving to be a highly useful adjunct to 
mammography.  The wide acceptance of ultrasound as a diagnostic 
modality has been documented extensively in literature.  However, 
opinions vary about the usefulness of USG breast in the evaluation 
of masses, and, surgeons are cautioned to be aware of its attributes 
as well as its deficiencies. 
 The ‘Modified Triple Test’ utilizes-clinical Examination, 
Ultrasonography of the breast as the radiological method, and 
FNAC/ CNB for the diagnosis of palpable breast lumps; and it is 
gaining acceptance with the recent advances in technology and 
refinements in the interpretative criteria of sonographically 
characterized masses. 
 Today the studies concentrate on whether a benign result of 
the tests mentioned above makes excision biopsy unnecessary. Most 
often, this question arises in connection with localized changes in 
breasts with Fibrocystic diseases.  For these tests to be adopted they 
must however, have the some degree of accuracy as excisional 
biopsy-because, non-excision of a malignant tumor is unacceptable. 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
Medical literature abounds with studies of evaluation of breast 
lumps that emphasizes that the statement “every palpable mass must 
be assessed and clarified”. 
Hermansen C.et.at in 1987 prospectively studied 650 breast 
tumors and applied the term ‘Triple test’ to the triad of clinical 
examination; mammography and FNAC used to diagnose tem. He 
concluded that the diagnostic accuracy of the triple test is 
comparable to that of histological examination.  Hardy JR. et al 
assessed 143 patients with palpable breast nodules with clinical 
examination;  FNAC; mammography; ultrasonography and magnetic 
resonance imaging (MRI) and concluded that the combination of 
cytology and ultrasound was best at correctly diagnosing 
malignancy. 
Lawrence N Bassett et.al assessed the usefulness of 
mammography and sonography in women less than 35 years of age 
(1016women) during a 8 years period. This study found that 
mammography was not useful in women less than 35 years.  
However sonography was useful in avoiding unnecessary biopsies 
and for this reason was the initial examination in younger women.  
But it was not useful in detecting nonpalpable carcinomas or in 
differentiating benign from malignant solid masses. 
Vetto JJ et at in 1996 studied 55 women below the 
recommended age of screening mammography with the 3 elements 
of’ Modified Triple Test’(C/E, USG; FNAC/CNB).  The test had a 
specificity and negative predictive value of 100% for malignancy.  
They concluded that use of MTT for diagnosis of palpable breast 
lesions in younger women yields high diagnostic accuracy without 
the need for routine open biopsy, resulting in overall reduction in 
patient charges. 
Purasri P et al retrospectively assessed 603 patients with breast 
lumps using the ‘Quadruple test’- C/E/USG/Mammography/FNAC.  
A stepwise logistic discriminant analysis was used to derive a novel 
diagnostic index.  This predicted the diagnosis in 98% of women 
<35 years correctly. 
Hatada T et al retrospectively studied 114 lesions and 
compared diagnoses obtained by standard FNAC  and that of 
ultrasound guided FNAC with surgical findings and found the 
accuracy to be 65% and 86% respectively.  They concluded that 
USG-guided FNAC improves the preoperative diagnosis especially 
in patients with tumor less than 2cm. 
Heiken TT et al conducted a prospective analysis of office-
based breast ultrasound, on 660 breast lesions and found that 
suspicious lesions determined by USG had a 75% chance of being 
malignant; however 5% of lesions characteristic of fibroadenoma 
turned out to be malignancies. 
Jill S Montrey attempted to determine the usefulness of 
ultrasound as screening tool for breast cancer in women<35 years, 
with indeterminate mammography, persistent symptoms and high 
risk history. 
Literary review of Breast USG for screening:- 
Carcinoma detected 
Frazier et al 1092(3) 3/135 (2.2%) 
Kopens et al 1985(2) 3/127(2.4%) 
Basset et al 1987(1) 1/612(0.2%) 
Frazier et al 1985(4) 36/600(6%) 
  
 Thus breast ultrasonography when used correctly can be 
effective, but is not fool proof, especially in lesion<1cm. 
DISCUSSION 
ASSESSMENT OF BREAST LUMPS 
 Breast lumps are source of anxiety to patients and a stratified 
approach has to be adopted to properly (chart I) evaluate and treat 
them. Though benign breast diseases are more common; there is a 
preoccupation with malignancy (undue but understandable) amongst 
the patients and physicians alike. 
 The ultimate diagnosis and treatment of a patient with a 
dominant breast mass rests with the clinician.  A dominant breast 
mass is defined as a solid or cystic lump that persists throughout the 
menstrual cycle. 
 The pre op assessment of a breast mass begins with a through 
history and systematic physical examination.  However it is 
generally accepted that this alone can be inadequate for an accurate 
diagnosis.  The breast is naturally multinodular and hence the 
difficulty in appreciating small nodules amidst the normal lumpiness 
is apparent.  Apart from this is the varied expertise of the examiner 
in breast palpation.  Thus imaging of the breast using various 
physical imaging modalities is important. 
DIAGNOSTIC PROTOCOL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMMON BREAST SYMPTOMS 
LUMP NIPPLE DISCHARGE PAIN 
NODULARITY LUMP 
DIFFUSE 
SYMMETRICAL 
>30 YEARS, LOCALISED, 
ASSYMMETRICAL 
REASSURE 
TRIPLE TEST
PHYSICAL 
EXAMINATION 
IMAGING  TISSUE DIAGNOSIS 
The earliest recorded case of breast imaging is that 
SALOMON, a German pathologist who in 1913 reported the use of 
the recently developed X-ray to visualize breast structure in 
amputated breasts.  He demonstrated the  irregular mass density and 
microcalcification which are still in use as the most important 
benchmarks to identify possible breast malignancy.  Even today 
mammography remains the method of choice for detecting the 
occult, nonpalpable lesion and remains the standard for imaging of 
breast against which other modalities advocated now are measured. 
Other imaging modalities have now been introduced for  
¾ Visualizing lesion missed by mammography 
¾ To replace mammography with another efficient, more 
economic device. 
The diagnostic utility of ultrasonogram was document in 1950s; 
but it was only with the development of “grey scaling” by Korsakoff 
and associates in Sweden years later that better tissue representation 
was obtained.  Recent technical advances in ultrasonography have 
expanded the potential utility of this modality in the evaluation of 
breast lesions far beyond distinguishing solid abnormalities from 
cystic ones. 
Tissue diagnosis remains the most reliable confirmatory tool 
for breast lumps.  In 1912 Ward used fine needle aspiration (FNAC) 
Cytology to examine lymph nodes for lymphoma.  Eventually the 
procedure was attempted on patients with breast lumps in 1926 by 
Martin and Ellis at New York.  Cytological interpretation requires 
skill particularly in view of cell types and pathologies encountered, 
but high levels of accuracy can be obtained with experience. 
 
 
 
 
 
 
 
 
 
 
 
 
 
CLINICAL EXAMINATION 
A palpable breast mass may be identified when it becomes 
sufficiently large to be differentiated from surrounding breast tissue 
physically by an examiner – usually the patient or the physician; or 
is perceived on an imaging examination.  Determining by physical 
examination whether a mass is present can be difficult as all breasts 
are variable in the combination of glandular tissue, fibrosis and fat.  
True masses are generally asymmetric in relation to the other breast; 
distinct from the surrounding tissue and three dimensional. 
The underlying cause of complaints about the breast proves to 
be benign in the overwhelming   majority of cases.  Breast 
symptoms, however, induce such a great anxiety in the patient that 
malignancy needs to be excluded as speedily as possible. 
The first steps in this are the classic ones of history and 
physical examination. 
Essential points in the history include: 
¾ Age 
¾ Menstrual status 
¾ Family and reproductive history 
¾ Lactational history 
¾ Radiation to the chest  
¾ H/o benign breast disease 
¾ Previous biopsy 
In physical examination of patients with a breast complaint-
seclusion, warmth and privacy are particularly important in the 
examination of the breast.  This avoids discomfort and 
embarrassment to the patient.  Good lighting enables detection of 
minor abnormalities.  The patient sits stripped to the waist. Attention 
is paid to. 
Inspection from bed end : 
1. Arms by the side of the body. 
2. Arms raised straight above her head 
3. Hands on her hips pressing and relaxing 
Symmetry of nipples and breasts. 
1) Both Breasts are inspected 
 1) Position – Displaced in any direction. 
 2) Size& shape–Whether larger (or) Smaller than its fellow 
 3)  Any puckering (or) dimpling  
 
 
2) Skin over the Breast 
 1.Colour & Texture 
 2. Engorged veins 
 3. Dimple retraction 
 4. Peud’e orange 
 5. Nodules 
 6. Ulceration and fungation. 
3) Nipple: 
 1.Symmetry 
 2.Position 
 3.Size & Shape 
 4.Discharge 
4)  Areola  
 Colour, Size, Surface 
5) Arm & Thorax 
6)  Axilla & Supraclavicular fossa. 
Palpation: 
(1) Palpate Normal Breast first 
(2) All four quadrants should be palpate systematically along 
with axillary tail. 
(3) Deeply systematically from the areola concentrically. 
(4) If any lump is detected it is felt by palmar surface of the 
finger with hands flat site number size shape surface margin 
consistency should be noted 
(5) Fixity to skin, breast tissue and underlying fascia muscle is 
noted. 
Examination of Lymph nodes 
1) Axillary 
a. Pectoral group 
b. Brachial group 
c. Subscapular group 
d. Central group 
e. Apical 
2) Supraclavicular Nodes 
Examination of Other Systems : 
Particularly valuable in practice are 
a) Inspection with arms firstly dependent, then elevated 
b) Initial light touch over the breasts prior to systematic deeper 
palpation in concentric circles, working outwards. 
c) Simultaneous examination of the axilla performed from 
behind the patient. 
Malignant lesions may be firm and have indistinct borders and 
attachments to the skin or deep fascia with dimpling or nipple 
retraction.  Benign lesions typically have discrete borders, well 
defined margins and are mobile.  Cysts can be differentiated from 
solid lesions by palpation. 
Rosner et al reported that physical examination can correctly 
identify only 58% of 66 patients with cysts.  Significant discordance 
among experienced examiners may occur.  In one study surgeons 
performed physical examination independently and agreed on the 
need for biopsy in only73% of 15 masses subsequently proved 
malignant. (Boyd et al). 
Somers et al studies certain palpable abnormalities defined asa 
areas of thickening, prominence of tenderness without an associated 
dominant mass on physical examination; no suspicious 
mammographic lesion; and rubbery, firm, cystic soft mass, needle 
sensation by FNAC. The incidence of malignancy in these 
‘suspicious’ group was less than 1 % (1/106), leading to the 
conclusion that this subset of patients with palpable abnormalities 
did not require surgical biopsy. 
Nevertheless, the physical findings of benign disease and 
malignancy in its earliest stages may overlap; and without the use of 
FNAC and/or breast imaging, some palpable malignant lesions may 
be followed up inappropriately; leading to serious consequences for 
both the patient and the physician. 
Although some masses exhibit distinct physical findings, an 
imaging evaluation is required in almost all cases to characterize the 
palpable lesion, search for ipsilateral multifocal or multicentric 
carcinoma, and screen the contralateral breast. A negative imaging 
evaluation, however, should never over rule a strongly suspicious 
finding on physical examination or vice versa. 
 
 
 
 
 
 
 
 
 
ULTRASOUND OF THE BREAST 
Although diagnostic ultrasound equipment has been available 
since the 1950s, it is only in relatively recent years that the 
widespread use of this technique has been accepted by radiologists 
and then by surgeons.  A lot of this has related difficulties with 
earlier machines. 
HISTORY 
 The transducers that produce the ultrasonic signal were 
initially quite crude devices that operatively low frequencies.  
Although penetration of the signal is better at these frequencies, 
resolution of tissue abnormalities is not as good.  It was not until the 
development of ‘gray scaling’ by Korsakoff and associates in 
Sydney that better tissue representation was obtained.  As the name 
of the technique implies, the images now obtained were in shapes of 
gray and this shading was corresponding to tissue changes and 
particularly to areas of localized pathology.  Improvements in 
transducer design followed, allowing various frequencies to be used, 
with the higher frequencies used in areas such as the breast, thyroid 
and testis. 
 Colour Doppler provides additional information about the 
vascularity and helpful in characterization (Delorme & Huber 1998) 
Blood flow is demonstrated by frequency shift produced by 
movement of RBC.  Use of a microtubule contrast agent may further 
enhance detection of flow. 
 Even with all the advances it must be state and emphasized 
that the use of USG equipment is very operator dependant and 
interpretation of the images requires a large amount of practical 
training.  Skilled interpreters of ultrasonic images, do however, 
follow 3 golden rules- 
1. Never make an interpretation on a single image, 
superimpose the ultrasonic images mentally to formulate a 
3 dimensional of the scanned tissues and to ensure that the 
displayed feature is consistent with the 3D image. 
2. Because a feature is displayed it is not necessarily real- 
always rule out artefacts. 
3. Because a feature is not displayed it is not necessarily not 
there. 
The original use of USG was to determine whether a breast 
mass was a cyst or solid lesion.  Advances in technology and 
refinements in interpretative criteria have expanded the role of USG 
in characterizing masses as having benign, malignant or equivocal 
features. 
BREAST ULTRASOUND TECHNIQUE:- 
¾ Confirm the location of the mass noted on physical 
examination; a diagram from the referring physicians to 
demonstrate the lesions position. 
¾ A high resolution small parts transducer 7.5 – 15 MHz is used. 
¾ Evaluate the Region of Interest (ROI) to assess the clinical 
abnormality is corresponding to the ultrasound findings. 
¾ Patient positioning: The patient is positioned in an oblique 
manner with a pillow placed under the shoulder of the breast 
to be examined.  The degree of obliquity is determined by the 
breast – aiming to have the breast spread evenly over the chest 
wall, with the nipple pointing to the ceiling.  The arm should 
be elevated over the patients head to facilitate even distribution 
of the breast tissue, but should not be elevated that the breast is 
retracted superiorly.  A little care exercised in patients makes 
the USG localization of the lesion less of a problem. 
a. Lumps felt better in the upright position may by 
scanned in that position. 
b. Fluid levels in cystic masses may be confirmed by 
changing to upright/ decubitus position. 
¾ Region of interest is trapped with the examining finger and the 
transducer is placed directly over the abnormality. 
¾ Examine in overlapping radial/ antiradial planes – to determine 
relation of lesion to ducts and avoid errors as mistaking fat 
islands for solid masses. 
¾ The entire periphery of the lesion must be evaluated in 
multiple planes through a 180 degree are to determine the 
nature of margins, its shape and appearance of surrounding 
tissue. 
¾ Compression of tissue with the transducer is helpful in 
spreading apart breast tissues, flattening islands of fatty tissue, 
and eliminating artificial shadowing. 
¾ The rest of the breast tissue is systematically imaged from 
periphery to the nipple. 
¾ The retroareolar area can be evaluated with the transducer 
angled into the area in multiple planes. 
LABELING OF LESIONS: 
¾ The lesion is labeled on a clock face. 
¾ Its distance form nipple is given in centimeters. 
¾ The greatest diameter should be measured. 
¾ The height (AP diameter) is determined obtain a height/width 
ratio. 
NORMAL APPEARANCE OF THE BREAST  
 Knowledge of normal variations of breast architecture is 
essential for the detection and accurate diagnosis of abnormalities. 
Breast is seen on ultrasound as a multilayered structure, the skin and 
the fibroglandular plate being relatively echogenic while the 
subcutaneous and retromammary fat layers are echo poor. 
Skin: 
 The skin is imaged as an echogenic layer of approximately 
3mm or less in thickness, often a hypoechoic central line.  Large 
areas of skin thickening are difficult to recognize without comparing 
the ROI to the opposite breast or to a normal area with in the same 
breast.  A stand-off pad may be used to detect subtle abnormalities. 
 
 
SUBCUTANEOUS TISSUE: 
  The subcutaneous fat layer is a hypoechoic layer situated 
between the skin line and the breast parenchyma.  Cooper’s 
ligaments are imaged as curvilinear lines extending from the breast 
tissue to the superficial fascial layer- producing a scalloped 
appearance. 
Breast cancer does not arise in the subcutaneous but may 
involve it by direct extension. 
Focal increased echotexture; Malignancy, inflammatory 
lesions, edema, fat necrosis, or biopsy scar. 
Diffuse increased reflectivity; edema of any cause (eg., Heart 
failure ) diffuse, from of breast cancer, inflammatory breast cancer, 
inflammatory mastitis, or radiation therapy. 
Lesions indigenous to this plane are sebaceous cysts, 
epidermoid inclusion cysts, hemangiomas, and rarely smooth muscle 
and fibrous tissue tumors.   
NIPPLE AND AREOLA: 
 This is difficult area to visualize because of difficulties with 
transducer contact by nipple protrusion or inversion, producing air 
trapping which is a source of shadowing. Compression of the nipple 
and imaging with multiple planes angled toward the subareolar 
region can be help.  Ducts can be visualized and traced upon the 
breast tissue, echogenic areas within the ducts usually represent 
debris.  Visualization of a mass within a dilated duct may indicate a 
papilloma, carcinoma or other lesion. 
 
BREAST PARENCHYMAL LAYER: 
 The breast tissue is more dense and uniform in the younger 
patient, age and parity however, are not good predictors for the USG 
appearance for any one individual. 
 The breast parenchyma consists of ductal, lobular and fibrous 
tissue in varying proportions,.  The normal appearance of the breast 
can range form almost completely fatty with only a few echogenic 
fibroglandular tissue with little or no fat. Fibroglandular layer has a 
flat post surface while the anterior surface is cone shaped gathering 
towards the nipple. 
 Ductal elements can be made out in the glandular layer they 
are widest at the lactiferous sinuses under the areola but in the 
periphery of the gland as fine echo poor lines. 
 
RETROMAMMARY AREA: 
 It is a hypoechoic fat plane, superficial to the fascia pectoralis. 
Usually well demonstrated deep to the echogenic glandular tissue. 
LYMPHNODES, ARTERIES, AND VEINS 
 Lymph nodes are frequently imaged within the breast and 
axilla as oval nodules with an eccentric hyperechoic hilum and a 
surrounding less echogenic rim of tissue; 
Benign nodes -   large in size but maintain their morphology. 
Malignant nodes- only gross abnormalities can be detected, when 
they appear as lobulated hypoechoic nodules. 
Blood Vessels : 
 Normal vessels of the breast seen as coloured lines that 
typically run along normal structures.  They taper smoothly and 
branch regularly as they pass towards the gland. Colour Doppler can 
be used to demonstrate vascular structure within the breast and 
tumours. 
 
 
 
 
CHARACTERIZATION OF BREAST MASSES 
CYSTS: 
 The first step in characterizing breast masses is cyst/solid 
differentiation. When the breast meet all of the diagnostic criteria for 
cysts the USG accuracy approaches 100%. 
The criteria include: 
1. Round, oval lobulated shape 
2. Anechoic 
3. Well-defined posterior border  
4. Increased through and through transmission 
5.  No alteration of surrounding parenchyma 
Unfortunately, not all cysts display these criteria.  The 
resolution of USG for cystic lesions is up to 5 mm with 100% 
accuracy. 
 The presence of internal echoes is the most common 
diagnostic difficulty in cyst/solid differentiation.  Cysts have 
internal echoes due to  
¾ Presence of cholesterol or calcium 
¾ Hemorrhage 
¾ Infection 
FOLLOW UP OF CYSTIC LESIONS 
Chart-(2) 
SIMPLE CYST 
 
 
 
 
 
 
 
 
       COMPLEX CYST 
 
 
 
 
 
 
 
 
Follow-up USG at 4-6 months 
No malignant or indeterminate features 
observe
USG guided biopsy/cytological evaluation 
Confirm benign nature and observe 
Large complex /indeterminate cysts 
USG guided aspiration /presence intracystic mass 
Bloody or turbid aspirate 
SOLID MASSES: 
Ultrasound features of a solid includes: 
¾ Primary signs – Changes produced by the mass itself 
¾ Secondary signs – changes produced in the tissues surrounding 
a mass. 
BENIGN CHARACTERISTICS OF SOLID MASSES-   
The diagnosis of a benign nodule based on USG findings is 
rarely specific.  The appearance of fibroadenomas, focal fibrocystic 
changes, tubular adenomas and other benign solid nodules overlap.  
Characteristic of benign solid lesions include- 
1 Shape-oval, round with few lobulations. 
2 Margins that are sharply demarcated with a thin 
echogenic pseudocapsule. 
3 A depth/width ratio of <1 
4 No disruption of surrounding tissues 
5 Homogenous low level internal echoes are usually 
present. 
6 Move freely 
7 Compressible 
8 Low in vascularity 
9 Vessel architecture is simple 
 
 
Characteristic of malignant solid lesions: 
         Irregular with ill defined borders 
         Internal echoes are heterogenous   
Interrupt the surrounding breast architecture 
Drag the surrounding tissue as they are moved 
Incompressible 
Vascular 
Vessels are tortuous and irregular 
FIBROADENOMAS: 
They are most common benign solid nodules.  They are most 
commonly detected in the younger age group.  The USG appearance 
is determined by the relative amounts of fibrous and epithelial tissue. 
a) Enhanced through and through transmission 
b) Posterior attenuation in relation to the fibrous component 
c) Coarse calcifications in degenerating fibroadenoma 
producing shadowing. 
d) Tubular structures seen with lactating and juvenile types. 
e) Differentiated from fat lobules by their non compressible 
characteristics 
 
LIPOMAS AND FIBROADENOMYOLIPOMAS : 
1. Lobulated masses that do not distort surrounding tissues 
2. Presence of internal echoes due to fat. 
FAT NECROSIS: 
 Focal hyperechoic nodule with a central lucency 
MALIGNANT CHARACTERISTICS OF BREAST LESIONS 
 Stellate masses 
 Circumscribed masses 
 Diffuse edema changes 
 Calcifications. 
Stellate masses:  
Desmosplastic reaction produces contraction of the breast 
tissue towards the mass disrupting the normal parallel soft tissue 
planes. 
¾ These masses have an irregular hypoechoic lesion with 
distortion of the surrounding breast tissue. 
¾ Disruption of normal trabecular structures. 
¾ Extension along the plane of the ducts. 
¾ Posterior acoustic shadowing. 
¾ Increased reflectivity of the subcutaneous tissue. 
DD of stellate lesions: 
¾ Carcinoma (Most common) 
¾ Radial Scar 
¾ Sclerosing  adenosis 
¾ Post surgical scarring 
Circumscribed masses:   
Breast cancer also commonly presents as hypoechoic masses that 
appear to displace breast tissue. 
¾ Oval, round 
¾ Multilobulated  
¾ Height/width ratio>1 
¾ >3 lobulations 
¾ Reactive halo surrounding the mass 
DD of circumscribed masses: 
¾ Carcinoma – Usually the high grade NOS variety of ductal 
carcinoma & medullary colloid and papillary ca., 
¾ Metastatic lesions:- from lymphoma melanoma leukemia, 
sarcoma, adenocarcinoma from other sites. 
¾ Inflammation and abscesses. 
¾ Hematoma 
¾ Phylloides tumor 
¾ Fibroadenoma. 
Diffuse edema changes: 
 A difficult type of carcinoma to distinguish is one that does no 
produce a mass but only diffuse changes in echotexture and 
parenchymal pattern. 
¾ Subtle increased reflectivity of parenchyma and 
subcutaneous fat. 
¾ Loss of normal orientation of tissue planes. 
¾ Poor differentiation in the fat-parenchyma interface. 
DD of diffuse edema: 
¾ Lobular and ductal carcinoma, inflammatory carcinoma. 
¾ Breast contusion 
¾ Congestive cardiac failure (usually bilateral). 
¾ Breast/chest wall irradiation 
¾ Superior vena cava obstruction. 
¾ Axillary lymphatic obstruction. 
 
 
 
Calcifications:   
Breast carcinoma may produce calcifications both with and 
without mass.  Calcification of sufficient size and clustered variety 
in a homogenous tissue can be picked up by USG. 
Intracystic  carcinomas :  
Rare lesions, usually papillary carcinoma that has obstructed a 
duct and bled producing a blood filled cyst. 
DD f intracystic mass: 
• Papillary carcinoma  
• Necrotic solid tumor 
• Cysts containing hemorrhage, debris 
• Abscess 
• Hematoma 
With the aid of the above criteria USG can come to a reliable 
diagnosis of breast lumps, depending upon the size of the lesions.  
The minimum size of cystic lesions picked up by USG are 2-3 mm. 
Solid lesions> 0.5cm are usually categorized with accuracy, 80% of 
solid lesions > 2cm and, 20% of lumps > 1-2cms and 5% of lump < 
1cm is the diagnostic accuracy of USG. 
 
 NORMAL BREAST : Showing subcutaneous tissue, glandular tissue(G), retromammary fat(RMF), 
nipple shadow(S), pectoralis muscle(M). 
 
PANORAMIC VIEW OF NORMAL RIGHT BREAST. A whole breast section can be shown using 
extended field of view software. 
 
 CYSTIC MASS: Anechoic mass with regular margins and posterior acoustic enhancement. 
 
                
MULTIPLE SIMPLE CYSTS: Anechoic cystic masses with regular margins and posterior acoustic 
enhancement. 
 
 
 
 
 
CYST 
  
          
USG GUIDED ASPIRATION OF SIMPLE CYST: Showing needle in situ and reduction in size of 
the cyst following aspiration  
 
 
 
            
          COMPLEX CYSTIC LESION: Cystic lesion with septations and internal  
                                                               echoes. 
 
     
 
 
  
                      
ABSCESS: Cystic lesion with irregular margins with debriduous materials and posterior acoustic 
enhancement. 
 
 
           
FIBROADENOMA: Hypoechoic mass with regular margins, predominantly transverse. Doppler 
study shows peripheral vessels. 
 
 
  
 
 
ABSCESS 
  
                        
LARGE FIBROADENOMA: Well circumscribed, homogenously hypoechoic solid mass with 
minimal posterior enhancement. 
 
 
           
SOLID MASS: Irregular margins, mixed echogenicity – Suggestive of Malignancy. 
 
MASS 
MASS 
 
        
    MALIGNANCY: Hypoechoic lesion, predominantly anteroposterior growth,  
                                Irregular  margins with distortion of surrounding tissue. 
 
 
                  
           MALIGNANCY: Irregular mass with mixed echogenicity, downward growth. 
 
 
MASS 
              
SUSPICIOUS LESION: Well circumscribed, oval hypoechoic lesion which turned out 
                                         to be malignancy. 
 
 
                              MALIGNANCY: Irregular intracystic mass 
 
 
 
 
MASS 
  
      
               INTRADUCTAL CARCINOMA: Irregular mass within a dilated duct 
 
    
              Doppler study of malignant lesion shows penetrating vessels. 
 
 
 
M 
 
  
 
          
                                   MALIGNANCY WITH CALCIFICATIONS 
 
 
       
                  ENLARGED AXILLARY LYMPH NODES: Rounded, multiple nodes 
INDICATIONS FOR BREAST ULTRASOUND 
From the above discussion we can summarise the now 
standardized indications for Breast Ultrasound follows: 
1 Evaluation of a palpable lump or mammographic abnormality 
2 To confirm the existence of a lesion and its nature. 
3 Single imaging modality in pregnant or lactating patient who 
present with symptoms. 
4 To differentiate solid from cystic lesions. 
5 For pathological examination of indeterminate lesions-guided 
FNA/CNB can be carried out. 
6 Pre operative localization of lesions with needle placements, 
documentation of lesion removal by USG of biopsy specimen. 
7 Follow up of surgically layer to the biopsy scar on skin, as 
well as for guidance for FNA/CNB. 
8 Follow up after augmentation mammoplasty to detect 
extracapsular rupture /contour abnormalities of the prosthesis.   
9 Follow up of probably benign lesions that have not been 
biopsied. 
10 Adjunctive to mammography as a screening tool for 
Carcinoma breast. 
 
ADVANTAGES OF USG OVER BREAST MAMMOGRAPHY 
1 No risk of radiation and its inherent consequences. 
2 Can qualify a lesion-as size, shape, echogenicity and relation 
to surrounding tissues as against a mammographic report of a 
‘density’ which is less specific.  
3 Sonographically guided biopsies are more accurate than 
stereotactic biopsies as the needle can be visualized in real 
time throughout the entire procedure. This adds confidence 
that the biopsy sample was obtained from the lesion. 
4 Mammographic positioning for pre-operative localization of 
the masses is cumbersome and time consuming and less 
accurate.  Hence USG is the modality of choice for guidance. 
5 Surgically altered breast has confusing findings and is non-
informative on mammography. 
6 Palpable lumps following extracapsular rupture of prosthesis 
may be impossible to image by mammography. 
7 Long term follow-up of benign nodules not excised is 
associated with risk of radiation on mammography and hence 
best performed by USG. 
 
LIMITATIONS OF BREAST ULTRASOUND 
Breast ultrasound usage is avoided in certain situations where no 
efficacy has been documented. 
1 Routine evaluation of post operative breast. 
2 Cancer Screening – as USG cannot detect all the non-palpable 
cancers that are also missed on mammography. 
3 Cannot detect microcalcification well: small solid lesions in 
fatty or mixed breast tissue are not sonographically visible. 
4 High false negative rate for non palpable cancers, (23%) which 
are smaller, clinically occult. 
5 Substantial false positive rate-sonogram may pick up ’lesions’ 
which are rarely clinically significant. 
6 Unreliable in lesions<1cm. 
7 Less accurate in dense breasts. 
These data suggest that breast ultrasound can be useful both as 
a single imaging modality and as an adjunct of mammography in 
evaluation of patients with breast lumps.  In addition, ultrasound 
facilitates preoperative needle biopsy of non-palpable abnormalities, 
permitting timely and cost effective patient care. 
 
 MRI for Screening: 
 For high risk patients having life time risk of 15-20% 
 Have extremely dense breasts or unevenly dense breasts 
 
Why MRI is not recommended for screening all women? 
 Major disadvantage is that breast MRI screening results has 
more false positives.  If breast MRI were adopted as a screening tool 
for everyone, many would end up having unnecessary biopsy and it 
is also more expensive.  
 
 
 
 
 
 
 
 
 
 
FINE NEEDLE ASPIRATION CYTOLOGY 
The advent of cytology and availability of experienced 
cytologists has diminished the diagnostic of excision biopsy 
especially with regard to breast lumps. 
FNAC can play a significant role in the early diagnosis of 
breast lumps a rule out malignancy, as an attractive alternative to 
open biopsy.  It is our responsibility to further the integrity of this 
important procedure by understanding the merits and pitfalls of 
breasts FNAC and adhering to the defined guidelines. 
HISTORY: 
 Martin and Ellis in 1926, New York first introduced the 
concept of FNAC in the midst of controversies regarding the 
credibility of the procedure. Breast FNAC is a simple complex 
procedure that is influenced by many variables.  Accurate 
interpretation of breast FNAC requires clear guidelines for specimen 
acquisition, staining and preparation. 
Bamforth in 1966 defined cytology as; “The examination of 
cells obtained by needle or drill biopsy in solid organs or tissue 
masses or form cut surface of such materials freshly removed by 
surgical biopsy. 
Innumerable studies have now shown that cytological 
examination of cells obtained this way is a rapid and reliable method 
of diagnosing malignant diseases of the breast. 
REQUIREMENTS: 
1 Spirit swab to clean the skin.   
2 Disposable 10ml or 20ml syringe with fine needle 
22G/23G. 
3 A number of 76mmx26mm microscopic slides 
4 Fixatives like cytofix solution which is a commercial 
preparation, containing absolute alcohol as its main 
constituent. 
5 Transport box for prepared slides  
6 Complete lab. Request form giving patient’s particulars 
PROCEDURE: 
 The procedure is usually performed without anaesthesia.  Very 
rarely local anaesthesia is used.  Local anaesthesia is generally not 
necessary because it is painful and may obscure the mass. 
1 The skin over the lump is wiped with antiseptic solution and 
the lump is fixed between the fingers and the thumb and held 
steadily for needling then needle is guided through the skin 
into the lesion. 
2 Once the needle is felt to enter the lesion, the plunger is 
retracted to create vacuum. Should be the lesion prove to be 
cystic the fluid should be aspirated in its entirety and 
expressed into a universal container and sent for cytological 
examination. 
3 In the lump is found to be solid, the needle in gently moved 
back and forth into the substance of the tumor three or four 
times and is inserted into a different part of the tumor each 
time to dislodge the cells from the tumor, Dixon et al 1998.30 
so that the aspirate will contain the sufficient material for 
cytological studies. 
4 Throughout the technique a negative pressure must be 
sustained in the syringe.  Only after the tumor has been 
repeatedly probed, should suction be released and the pressure 
in the syringe allowed to return gradually to atmospheric 
pressure and the needle is withdrawn from the breast.  The 
pressure in the syringe must be adjusted in a way so that the 
aspirated cells are retained in the lumen of the needle (Leinster 
2000:53) sustained suction as the needle is withdrawn result 
in, the cells being withdrawn into the barrel of the syringe 
rendering them inaccessible for processing . 
PREPARATION OF ASPIRATE: 
 It is possible to make smear directly from the aspirate in the 
outpatient department.  Alternatively, the aspirated cells can be 
suspended in fixative and transferred to cytologic laboratory for 
processing. 
PREPARATION OF SMEAR: 
• After aspiration the needle and syringe are withdrawn 
from the skin  
• Although nothing is visible in the syringes cells should 
have collected inside the bore of the needle. 
• The needle is disconnected from the barrel, the syringe is 
filled with air. 
• A clean glass slide should be ready and the needle is 
reconnected to the barrel and the aspirated material is 
blown out into the slide. 
• Any large tissue fragments which do not spread easily be 
crushed between the cover slip and slide. 
• The smear is air dried and fixed in cytofix solution.  
Then the slide is duly labeled. 
FIXATIVES: 
A number of fixatives are used cytology- 
•  95% Ethyl alcohol 
• 95% Ethyl Alcohol with 3% glacial acetic acid – to improve 
the nucleoprotein fixing properties. 
STAINING PROCEDURES: 
Some cytopathologists prefer to interpret these slides stained 
• Papanicolaou method – when available this may be preferred 
in cytology for its superior display of nuclear morphology and 
clear translucent demonstration of cytoplasm. 
• Hematoxylin and Eosin method. 
 
 
 
 
 
 
 
NORMAL CYTOLOGY OF THE BREAST 
The mammary gland is a compound glad made up of independent 
units containing their own ducto-alveolar systems. 
The alveoli are lined by simple cuboidal or low cuboidal 
epithelium which may alter in size depending on the secretary status 
of the breast. The ducts are also similar in lining, becoming 
pseudostratified along the main lactiferous and stratified as the 
approach the nipple. 
The typical cytological features in different breast condition are 
given below. 
BENIGN: 
FIBROADENOMA: 
• Duct cells are seen in large group and sheets surrounded by 
‘stripped” nucleus  (Housami at as 2001.18th) 
• Monolayered groups of cohesive ductal cells 
• Stromal tissue fragments 
• Abundant naked nudes  
FIBROCYSTIC DISEASE: 
• Numerous small foam cells and large metaplastic apocrine  
cells with acidophilic cytoplasm. 
• Dark pyknotic nuclei,  
• Sheets and clusters of uniform elongated cells; with 
transparent cytoplasm and having dendritic processes. 
PLASMA CELL MASTITIS: 
• Foam cells and sheets of degenerate epithelial cells are 
common. 
• Lipid containing macrophages and occasional foreign body 
giant cells. 
• Diagnostic feature is presence of large amounts of 
plasmacytes, Lymphocytes and eosinophils and few 
neutrophils. 
MALIGNANCY: 
There are structured criteria for the diagnosis of malignancy by 
cytology, which are stratified into: 
• Structural alterations in the cells 
• Changes in inter relationship of cells in cell clusters 
• Indirect criteria. 
 
 
   
 
NORMAL BREAST CYTOLOGY: Loose fibrofatty tissue – Ramifying 
channels of  fibrous tissue 
   
 
FIBROADENOSIS: Hyperchromatic epithelial cells and cyanophilic 
connective tissue 
 FIBROADENOMA: Epithelial cells in cohesive sheet. Identical with each other 
and bland nuclei. 
   
 
INTRADUCTAL CARCINOMA: Discrete dissociated malignant cells with 
small pear shaped nuclei. 
 
Structural modifications: 
• Alteration of nuclear cytoplasmic ratio with disproportationate 
enlargement of nuclei. 
• Hyperchromasia due to increased chromosomal content, 
aberrant chromatin pattern. 
• Increased number of nucleoli beyond the normal. 
• Multinucleation with nuclear atypia, abnormal mitotic figures. 
• Marked thickening of nuclear membrane. 
• Cytoplasmic changes enhanced by staining, such as 
pronounced basophilia/acidophilia. 
• Presence of cytoplasmic inclusions like pigment granules, 
leukocytes and cellular debris. 
• Atypical vacuolation especially in adenorcarcinoma. 
Cell-Cell changes: 
• Enlargement of cells beyond normal shape 
• Aberrant forms with associated nuclear atypia 
• Degenerative or necrotic changes. 
• Lack of uniform orientation of cells and nuclei 
• Anisocytosis/anisokaryosis-with marked variation in size of 
cells/nuclei within the same cell cluster. 
• Loss of distinct cell boundaries. 
• Dense grouping of and crowding of cells and nuclei. 
• Engulfment of one cell by another. 
• Cells grouping into characteristic patterns. 
Indirect Changes: 
• Presence of blood. 
• Increased Lymphocytes 
• Prominent histiocytes and polymorphonuclear cells. 
 
ADVANTAGES OF FNAC: 
1 Does not require anaesthesia. 
2 Tolerated by patients as an OP procedure  
3 No specialized equipment required. 
4 No damage to breast tissue that may occur with open 
biopsy 
5 Though small hematomas may be encountered, neither 
hemorrhage nor sepsis is noted. 
6 Remote chances of tumor seeding along needle tract. 
7 Lymphatic/vascular dissemination of tumor is virtually 
unknown. 
8 Can easily diagnose cysts / abscesses and treat them. 
9 Eliminated need for open biopsy when a diagnosis of 
carcinoma is made that is the incidence of false positive 
in malignancy is almost nil. 
10 Can be easily repeated. 
LIMITATIONS 
FNAC is analogous to looking through a key note to see an in entire 
room.  Only a small portion of a lesion is sampled. 
1. Cannot qualify the type of malignancy 
2. False negative reporting when 
a. Small tumors <1cm 
b. Sclerotic lesions 
c. Deep seated tumors 
d. Large/pendulous breasts 
e. Lesions beyond the length of the needle. 
 
 
 
CORE NEEDLE BIOPSY (CNB) 
 Dominant lumps>2cm in diameter can be proposed by a wide 
bore cutting needle; such as the Tru-Cut needle that has the 
advantage of producing a core of tissue which can be paraffin 
embedded and used as a normal histological specimen with a 
modern spring loaded device, with a local anaesthesia to the skin; a 
series of high quality cores can be obtained rapidly and almost 
painlessly. 
ADVANTAGES: 
• Ability to obtain a core of tissue that is sufficiently large for 
HPE 
• Providing more details of tumor structure 
• Ability to distinguish between invasive and IDCA 
• Any pathologist can interpret the results obviating the need for 
special skill of a cytopathologist. 
• Large amount of prognostic information can be obtained 
including  
o Biological grade 
o Receptor level 
o DNA analysis 
DISADVANTAGES: 
• Risk of seeding the needle tract with tumor cells. 
• Biopsy should be adjusted to avoid carrying potentially 
malignant tissue into the chest wall. 
• False positive incase of radial scars  
• False positive incase of hard lesions, deflecting the needle into 
surrounding fat. 
Thus CNB can be adopted as an alternative office biopsy 
technique to FNAC carrying sensitivity of 89%. 
 
 
 
 
 
 
 
 
 
 
 
  
AIM OF THE STUDY 
The study is conducted  with the objective of assessing the 
combined and individual reliability of the Modified Triple Test in 
making a pre-procedural diagnosis of palpable breast lumps. 
The components of the Modified Triple Test are: 
1. Clinical Examination(C/E) 
2. Breast  Ultrasonogram  (USG) 
3. Fine Needle Aspiration Cytology/Core Needle Biopsy 
(FNAC/CNB) 
 
 
 
 
 
 
 
 
 MATERIALS AND METHODS 
 
 A prospective cross sectional study of 90 female patients 
attending the outpatient department at the Department of General 
Surgery, Government Rajaji Hospital, Madurai, with the complaint 
of a palpable lump/lumps in the breast was undertaken. 
 Male patients and female patients with advanced Breast 
Cancer that makes diagnosis obvious were excluded from the study 
(n=33) 
 The inclusion criteria were: 
1 Females>30 years. 
2 C/o breast lump – clinically palpable as a localized 
lesion differing from the surrounding breast tissue. 
Each patient was put through the Modified Triple Test.  On the 
basis of a systematic clinical examination, the lumps were grouped 
as – Malignant, Benign and inconclusive. 
Ultrasound of the breast was performed by a Radiologist using 
a ALOKA SSD 4000 ultrasound machine with a 10MHz  probe.  
The lesions were classified as Malignant, Benign or Inconclusive 
based on the following features. 
a. Malignant – ill defined, heterogeneous mass with sharp 
angulations; presence of microcalcifications. 
b. Benign lesions were either cystic or solid. 
Cysts – Round, oval, anechoic, well defined with through and 
through transmission in simple cysts.  Abscesses show low level 
internal echoes. 
Ultrasound examination also included the contralateral breast, 
axillae and internal mammary lymph nodes.  For deeply seated 
lesions Sono-guidance was utilized to aspirate cysts and to take 
biopsies. 
After this, FNAC/CNB was performed by the attending 
surgeon and sent for cytological/ Histopathological examination. 
 
FNAC was reported as follows: 
a. Insufficient materials: Cell content in the aspirate too 
 poor for cytological assessment. 
b. Benign cells  Sufficient material with benign cells   
     indicating Fibroadenoma  or   
     Fibrocystic disease. 
c. Atypical cells:  Slight atypia; interpreted as benign 
lesion. 
d. Suspicious:   Malignancy – suspect cells; not  
     interpretable as carcinoma with  
     certainty. 
e. Carcinoma:   Cells indicative of malignancy. 
 
Results were interpreted as follows: 
a   - repeat FNAC/CNB 
b ,c - benign 
d - inconclusive  
e - malignant 
 The results of the modified Triple Test were then   analysed 
individually and as a combination.   Any component indicating a 
malignant report were taken as malignancy.  Inconclusive reports 
were subject to excision biopsy on an inpatient basis.  Patients with 
malignancy were treated with definitive surgery.  The post 
procedural histopathological reports were compared to the results of 
the Modified Triple Test. 
 
 
 
 
DATA ANALYSIS 
 
 Of the patients randomly referred for the study (n=90), patients 
not fitting the inclusion criteria were excluded (n=33). Thus 57 
patients with breast lumps were inducted into the study. 
  Thus the final study group (n=57) under went the MTT 
followed by excision biopsy, the results of which were available for 
comparison. 
 The average age of women in this study was 41.84+9.1.  The 
shifting to 47 years in patients with malignancy, the youngest was 30 
years and the oldest was 68 years.  This conforms with the suitable 
age for subjecting patients to screening procedure followed 
worldwide (i.e.) above 40 years.  9 women were nulliparous of 
which only 3 had malignant lesions.  The rest (n-48) were 
multiparous.  The results do not point to any positive association 
between parity and malignancy (p>0.05). ( Table:1) 
 
 
 
 
TABLE:1 
ASSOCIATION BETWEEN PARTY AND BREAST PATHOLOGY 
 
Parity Malignant Benign 
Nulliparous 3 6 
Multiparous 21 27 
     
P>0.05 
 Benign lesions were more common amongst premenopausal 
women (n=33): though malignancy could not be excluded in this 
group (n=24). However all the lesions detected in perimenopausal 
(n=5) postmenopausal women were malignant (N=6 Table-2) 
TABLE: 2 
ASSOCIATION BETWEEN MENSTRUAL STATUS AND 
MALIGNANCY 
Menstrual status Malignant Benign 
Postmenopausal 6 0 
Perimenopausal 5 0 
Premenopausal 13 33 
     P<0.001 
 On excision biopsy, the 57 lumps were confirmed 
histopathologically as  either Malignant (n=24) and Benign(n=33) 
The pathological reports were: 
Total no. of malignancies            = 24 
       Intra Ductal Carcinoma             = 21 
       Lobular Carcinoma             = 1 
       Medullary Carcinoma    = 1  
       Malignant cystosarcoma  Phylloides           = 1 
Total no. of Benign lesions   = 33 
       Fibroadenoma     = 14 
       Fibrocystic Disease    = 10 
       Breast Abscess     = 6 
       Benign cystosarcoma Phylloides  = 3 
 The associations between each component of MTT and the 
combined MTT with the biopsy report were subjected to computer 
generated analysis. 
 Clinical examination finding of a hard, irregular lump was 
more likely to be malignant, while a soft or firm mass with regular 
surface suggested benign lesions (p>0.000).  Benign lesions most 
often confused with malignancy were Benign cystosarcoma  
phylloides  & Fibrocystic disease.(Table-3) 
Table:-3 
Consistency Malignancy Benign 
Hard 18 3 
Firm 5 30 
Soft 0 1 
Surface   
Irregular 18 6 
Regular 6 27 
 
 The initial indications of USG in differentiating a solid from 
cystic lesions may be non beneficial in coming to a correct 
diagnosis.  Our study shows no association between the character of 
the lesion and diagnosis (p>0.05) Table-4 
 
Table-4 
ULTRASOUND FINDINGS AND HPE 
 Malignant Benign 
Cystic  2 6 
Solid 22 28 
     p> 0.05 
 
 A regular, well defined hyperechoic lesion was usually benign.  
An irregular; ill defined mixed echogenic mass indicated 
malignancy.  Hypoechoic lesions were not characteristic of either 
(p=0.05) Echogenicity could not thus be used as a singular feature to 
rule out malignancy except when they were hyperechoic. (Table-5) 
TABEL:5 
ECHOGENICITY OF LESIONS AND HPE: 
Echogenicity  Malignant Benign 
Mixed  10 6 
Hypoechoic 14 23 
Hyperechoic 0 4 
 
     P = 0.05 
 
 Ultra sound detected axillary nodes in all patients ( n = 12 ) 
found to be clinically node positive, however it could not distinguish 
whether the node had malignant infiltration or not.  
 
 Ultrasound guided FNA / CNB was done in 6 cases; 2 of 
which were cystic lesions with a residual mass on aspiration of the 
cysts.  Both turned out to be malignancies missed on routine FNAC. 
 
 Amongst the individual tests; clinical examination was more 
likely to miss a malignancy (Sensitivity 75%), as against ultrasound 
(Sensitivity 92%) or FNA / CNB (Sensitivity 100%) FNA / CNG 
correctly identified malignancy in all 24 cases; while ultrasound 
misinterpreted 1 case as malignant (a case of benign cystosarcoma 
phylloides) with specificities of 100% and 85% respectively. 
 
 The MTT was 85% specific with malignant lesions.  But 5 
cases were misdiagnosed as malignancies and turned out in 3 cases 
to be Fibrocystic Disease and 2 cases were benign cystosarcoma 
phylloides – both benign lesions.  Inconclusive results (n=4) on 
MTT were also confirmed to be benign lesions.  Thus MTT, though 
had false positives with respect to malignancy but no false negatives 
(ie.) a negative predictive value of 100%.  These data responsible to 
the original triple test with its sensitivity (65% - 96%) and specificity 
(55%-98%) as reported in various studies. (Tables 6-10) 
 
 
 
 
 
TABLE - 6 
ASSOCIATION BETWEEN CLINICAL EXAMINATION AND 
HISTOPATHOLOGY RESULT 
CLINICAL 
EXAMINATION 
HISTOPATHOLOGY 
Malignant Benign 
Malignant 18 1 
Benign 1 23 
Inconclusive 5 9 
 
 
 
TABLE – 7 
ASSOCIATION BETWEEN ULTRASONOGRAM AND HPE 
 
ULTRASONOGRAM HPE 
Malignant Benign 
Malignant  22 3 
Benign 1 28 
Inconclusive 1 2 
 
 
  
 
 TABLE – 8 
ASSOCIATION OF FNA/CNB WITH HPE 
 
FNA/CNB HPE 
Malignant Benign 
Malignant 24 0 
Benign 0 27 
Inconclusive 0 6 
 
 
 
 
 
TABLE – 9 
ASSOCIATION OF MODIFIED TRIPLE TESTS WITH HPE 
 
MTT HPE 
Malignant Benign 
Malignant 24 5 
Benign 0 24 
Inconclusive 0 4 
 
 
  
 
STATISTICAL ANALYSIS  
 C/E USG FNA/CNB MTT 
Sensitivity 75% 
(53-80%) 
92% 
(72-99%) 
100% 
(83-100%) 
100% 
(83-100%) 
Specificity 97% 
(82-100%) 
85% 
(67-94%) 
100% 
(87-100%) 
85% 
(67-94%) 
Positive 
Predictive 
value 
95% 
(70-99%) 
81% 
(61-93%) 
100% 
(83-100%) 
83% 
(64-93%) 
Negative 
predictive 
value 
84% 
(64-90%) 
93% 
(76-99%) 
100% 
(87-100%) 
100% 
(85-100%) 
‘p’ value < 0.001 < 0.001 < 0.001 < 0.001 
 
         FNAC / CNB as a single test was a superior diagnostic test 
than the other two tests, but only when complemented by them could 
the lesion be characterized in all dimensions for the chosen 
interventional procedure. 
           When an inconclusive was reported the likelihood of 
malignancy increases in ascending order form FNAC / CNB, USG to 
C/E (n=0, n=1, n=5 respectively).  All 4 cases deemed inconclusive 
after MTT were later diagnosed as Fibrocystic disease.  
 
 
CONCLUSION 
                    Detection and management of a breast mass requires an 
optimal environment for interpretation,   relevant use of clinical 
information, technically excellent imaging procedures, proper 
interpretation of finding and pertinent recommendations. 
                Our results show that the diagnostic accuracy of combined 
physical examination breast USG and FNA/CNB is comparable to 
that of histological examination. 
                A fine collaboration between experienced radiologists, 
cytologist and the clinician is required. Ultrasound when replacing 
mammography serve as effective  an imaging modality in palpable 
breast lumps and is more comprehensive. 
              Ultrasound breast aids biopsy techniques by guidance to the 
representative area than increasing yield. 
              CNB is a suitable alternative when FNA is inconclusive and 
may offer additional information. 
                Thus the use of MTT to complement findings in 
differential diagnosis of a lesion in a symptomatic women seeking 
medical care deserves acceptance and further evaluation.  This may 
lead to less delay in treatment when malignancy is suspected and to 
avoidance of surgical exploration when a benign nature of lesion is 
suspected. 
 SUMMARY 
 
          Among the 3 components clinical examination has sensitivity 
of 75%.  So malignancies are likely to miss. When combined with 
other 2 components having 92% and 100% sensitivity for USG and 
FNAC / CNB respectively.  MTT has 100% sensitivity, 85% 
specificity which is comparable with original triple assessment 
which has sensitivity of 65 – 96% and specificity of 55-98% .  
Though MTT had false positives for malignancy there are no false 
negatives.  The false positives are due to fibrocystic disease and 
benign cystosarcoma phylloides. 
 
 
 
 
 
 
 
 
MASTER CHART 
S.No.  NAME  AGE  I.P.No 
Mens 
H/o 
Parity
Clinical Examination  Usg Breast  FNAC CNB RESULTS  MTT 
HPE Consis Axillary Echog  Axillary  C/E Usg FNAC/
surface tency  Nodes  enicity  Nodes  CNB 
1  KARUPPI  45  82121  A  M  IR  H   ‐   ‐ 
 +   +   +   +   + 
IDCA 
2  LAKSHMI  47  84129  A  M  IR  H   ‐   ‐   ‐   +   +   ‐   ‐  FCD 
3  RAMA  45  88123  A  M  R  S   +   +   ‐   ‐   ‐   ‐   ‐  BA 
4  FIRTHASE  32  89161  A  M  R  F   ‐   ‐   ‐   ‐   +   +   ‐  FA 
5  KAMALA  40  92121  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
6  POONAMA  45  93141  A  M  R  F   ‐   ‐   ‐   +   ‐   ‐   ‐  FCD 
7  POOCHI  45  95123  AB  M  IR  H   ‐   ‐      +   +   +   +   +  IDCA 
8  JEYAM  35  98912  A  M  R  G   ‐   ‐   ‐   ‐   ‐   ‐   ‐  BA 
9  RAKKU  40  99121  A  M  IR  G   ‐   ‐      +   ‐   ‐   +   ‐  IDCA 
10  MADACHI  59  412  B  M  R  H   +   +   +   +   +   +   +  IDCA 
11  RANI  47  479  A  N  IR  H   +   +      +   +   +   +   +  IDCA 
12  MARY  47  576  B  M  IR  H   +   +   +   +   +   +   +  IDCA 
13  KAVITHA  32  791  A  N  R  G   ‐   ‐   ‐   ‐   ‐   +   +  FCD 
14  MAHA  32  992  A  N  R  G   ‐ 
 
 ‐   ‐   ‐   ‐   ‐ 
 + 
FA 
15  LALITHA  40  1121  A  M  IR  H   +   +   +   +   +   +   ‐  IDCA 
16  MANI  35  1341  A  N  IR  H   +   +   +   +   +   +   +  IDCA 
17  RAMUTHAI  40  1472  A  M  IR  H   +   +   +   +   +   +   +  IDCA 
18  HAMSA  35  1739  A  M  R  F   ‐   ‐      +   +   +   +   +  IDCA 
19  RADHIKA  35  1812  A  M  R  F   +   ‐   ‐   ‐   ‐   ‐   +  BA 
20  PALANIAMMAL  55  1923  B  M  IR  H   +   +   +   +   +   +  IDCA 
21  KALAMANI  35  2128  A  M  R  F   +   +      +   +   +   +   +  MCA 
22  NIRMALA  42  3133  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐   +  FA 
23  MILAFAR  41  4124  A  M  IR  H   ‐   ‐   ‐   +   +   +   +  FCD 
24  SEENIAMMAL  42  5151  A  M  R  F   +   ‐   ‐   ‐   +   +   +  BCSP 
25  POTHUMPONNU  52  6121  A  M  R  F   ‐   ‐   +   +   +   +   +  MCSP 
26  SADACHI  60  7129  B  M  R  F   +   ‐      +   +   +   +   +  IDCA 
27  SAMAYE  65  8131  B  M  IR  H   ‐   ‐   +   +   +   +   +  IDCA 
28  KASTHURI  38  9121  A  N  R  F   ‐   ‐   ‐   ‐   ‐   ‐   +  BA 
29  MANGALAM  59  11311  B  M  IR  H   +   ‐   +   +   +   +  IDCA 
30  PARVEEN  31  12119  A  M  R  F   ‐   ‐   ‐   ‐   ‐   +   +  FCD 
31  ANANDHI  31  13117  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   +  FA 
32  CHITRA  30  23119  A  M  IR  H   +   +   +   +   +   +   +  IDCA 
33  MERCY  35  24218  A  M  IR  H   +   ‐      +   +   +   +   +  IDCA 
34  RAJAMAL  41  24075  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
35  NOORJAHAN  36  25121  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
36  MALATHI  34  27824  A  N  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
37  KANNAKI  33  29121  A  N  IR  F   ‐   ‐   ‐   +   +   ‐   +  FCD 
38  SEETHAI  56  30122  AB  N  IR  F   +   +   +   +   +   +   +  IDCA 
39  KATHAYEE  40  31211  A  M  R  H   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
40  SELVI  34  41219  A  N  IR  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FCD 
41  SANGIAMMAL  46  42312  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
42  SAMAYEE  41  43912  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
43  UMA  35  44987  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  BA 
44  KRITHIGA  30  45679  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
45  VEERAYEE  56  57891  B  M  IR  H   ‐   ‐   +   +   +   +   +  IDCA 
46  POORNAM  49  67891  AB  M  IR  H   ‐   ‐   +   +   +   +   +  IDCA 
47  AMBIGAI  41  92124  A  M  IR  H   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FCD 
48  MYITHISH  38  73141  A  M  IR  F   ‐   ‐   ‐   ‐   ‐   +   +  FCD 
49  ANDAL  35  74121  A  M  R  F   ‐   ‐   ‐   ‐   +   ‐   +  BCSP 
50  REENA  34  75142  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  BA 
51  KRISHNAMMA  60  76121  AB  M  R  F   +   +   +   +   +   +   +  LCA 
52  NILOFAR  32  78224  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
53  PREMA  31  79124  A  M  R  F   ‐   ‐   ‐   ‐   ‐   ‐   ‐  FA 
54  SUBBAMMAL  48  80127  AB  M  IR  H   ‐   ‐   +   +   +   +   +  IDCA 
55  LAKSHMI  50  81243  A  M  R  F   ‐   ‐   ‐   ‐   +   ‐   +  FCD 
56  NACHAMMAL  40  82176  A  M  R  F   ‐   ‐   ‐   ‐   +   ‐   +  BCSP 
57  PACHAIAMMAL  52  83178  A  M  IR  H   ‐   ‐   +   +   +   +   +  IDCA 
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                                ABBREVIATIONS 
MENS H/O              A –Premenopausal 
                                 B – Postmenopausal 
                                 AB- Perimenopausal 
PARITY                  M- Multipara 
                                 N- Nullipara  
CLINICAL EXAMINATION 
           SURFACE     R- Regular 
                                  IR- Irregular 
           CONSISTENCY 
                                  H- Hard 
                                  F- Firm 
                                  S- Soft 
USG-ECHOGENICITY 
          -Hypoehoic 
          -Hyperechoic 
          -Mixed 
RESULTS 
      +   - Malignant 
      -    - Benign 
      +   - Inconclusive 
HPE 
                                 FA – Fibroadenoma 
                                 FCD- Fibrocystic disease 
                                 BA- Breast abscess 
                                 BCSP- Benign cystosarcoma phylloides 
                                 MCSP- Malignant cystosarcoma phylloides 
                                 IDCA- Intraductal carcinoma 
                                 MCA- Medullary carcinoma 
                                 LCA- Lobular carcinoma 
 
